Patents by Inventor Chris Fellows

Chris Fellows has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preclinical evaluation of skin condition and risk evaluation
    Patent number: 11911173
    Abstract: A system for quantifying risk associated with preclinical indicators of one or more clinical skin conditions, the system is formed of a plurality of measurement tools in connection with a processor, the measurement tools configured to various pre-clinical indicators of the skin health of a subject' hand, where the processor is configured to calculate a score based on the combined data from the plurality of measurement tools, this score being representative of the subject's risk of future development of one or more clinical skin conditions.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: February 27, 2024
    Assignee: Deb IP Limited
    Inventors: Paul Blount, John Hines, Caroline Fellows, Chris Lang, Chris Mann, Kevin Ormandy
  • Ablation stent for treating atrial fibrillation
    Patent number: 7209783
    Abstract: An apparatus and method for treating atrial fibrillation with ablation therapy in which a stent is deployed within a pulmonary vein and tissue surrounding the stent is ablated with radiofrequency energy to stop discharges from ectopic foci in the vein from reaching the left atrium. The deployed stent can then be left in place to prevent stenosis of the vein as well as allowing repeat ablation procedures as needed.
    Type: Grant
    Filed: April 16, 2002
    Date of Patent: April 24, 2007
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Chris Fellows, Wade A. Bowe, David S. Wood
  • Ablation stent for treating atrial fibrillation
    Publication number: 20030018362
    Abstract: An apparatus and method for treating atrial fibrillation with ablation therapy in which a stent is deployed within a pulmonary vein and tissue surrounding the stent is ablated with radiofrequency energy to stop discharges from ectopic foci in the vein from reaching the left atrium. The deployed stent can then be left in place to prevent stenosis of the vein as well as allowing repeat ablation procedures as needed.
    Type: Application
    Filed: April 16, 2002
    Publication date: January 23, 2003
    Inventors: Chris Fellows, Wade A. Bowe, David S. Wood